Morphic Therapeutic – Patient Worthy

source: pixabay.com

Oral Treatment for Inflammatory Bowel Disease Doses First Patients in Phase 1 Trial

Post author:Sunniva Bean
Post published:October 8, 2020
Post category:Inflammatory Bowel Disease Rare Disease ulcerative Colitis

As reported in BioSpace; trials for an oral treatment to treat inflammatory bowel disease (IBD) by Morphic Therapeutics has just dosed their first healthy subjects in the Phase 1 trial.…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More